PRC-063 in Adolescent ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

May 31, 2015

Conditions
ADHD
Interventions
DRUG

Placebo

Oral placebo capsule

DRUG

PRC-063 25 mg

Oral 25 mg capsule - active

DRUG

PRC-063 45 mg

Oral 45 mg capsule - active

DRUG

PRC-063 70 mg

Oral 70 mg capsule - active

DRUG

PRC-063 85 mg

Oral 85 mg capsule - active

Trial Locations (43)

20170

NeuroScience, Herndon

21205

Kennedy Krieger Institute, Baltimore

27612

Wake Research Associates, Raleigh

27705

Duke University Medical Center, Durham

32256

CNS Healthcare Jacksonville, Jacksonville

32607

Sarkis Clinical Research, Gainesville

Sarkis Clinical Trials, Gainesville

32751

Florida Clinical Research Center, Maitlin

32806

Clinical Neuroscience Solutions, Orlando

33143

Miami Research Associates, South Miami

33613

Stedman Clinical Trials, Tampa

34201

Florida Clinical Research Center, Bradenton

38105

Clinical Neuroscience Solutions Inc., Memphis

45219

University of Cincinnati, Cincinnati

73103

IPS Research Company, Oklahoma City

75231

FutureSearch Trials of Dallas, L.P., Dallas

77007

Bayou City Research Ltd, Houston

77090

Red Oak Psychiatry Associates, Houston

77098

Houston Clinical Trials, Houston

78229

The University of Texas Health Science Center at San Antonio, San Antonio

78731

FutureSearch Clinical Trials, L.P., Austin

83642

Advanced Clinical Research, Boise

84015

Ericksen Research, Clinton

84105

Physiciatric and Behavioral Solutions, Salt Lake City

89128

Center for Psychiatry and Behavioral Medicine Inc., Las Vegas

90095

UCLA, Los Angeles

91950

Synergy Clinical Research, National City

92663

Newport Beach Clinical Research Associates, Inc., Newport Beach

92868

Orange County Neuro Phychiatry Research Centre, Orange

98007

Northwest Clinical Research Center, Friday Harbor

98033

Eastside Therapeutic Resource, Kirkland

T2N 4Z6

Mathison Centre for Mental Health Research and Education, Calgary

University of Calgary, Calgary

T6L 6W6

Chokka Center for Integrative Health, Edmonton

V7V 3R8

Dr. Margaret Weiss, Vancouver

B2Y 1H6

Atlantic ADHD Centre, Dartmouth

Unknown

McMaster University, Hamilton

L2E 6A4

Doctors Jackiewicz Professional Medical Corporation, Niagra Falls

K2G 1W2

Dr. Judy van Stralen, Ottawa

M5G 1N8

Stress, Trauma, Anxiety, Rehabilitation and Treatment (START) in the Mood and Anxiety Disorders Clinic, Toronto

L1N 2L1

The Kids Clinic, Whitby

H3Z 1P2

McGill University Health Centre, Montreal

S7N OW8

Royal University Hospital Saskatoon, Saskatoon

All Listed Sponsors
collaborator

Purdue Pharma LP

INDUSTRY

lead

Rhodes Pharmaceuticals, L.P.

INDUSTRY

NCT02139111 - PRC-063 in Adolescent ADHD | Biotech Hunter | Biotech Hunter